News

Observational Study Planned for TAVR Patients at University of Cincinnati
June 5, 2020
June 5, 2020 — (Cincinnati, OH) A University of Cincinnati physician-researcher says unlocking the key to how platelets function before, after and during transcatheter aortic valve replacement (TAVR) may provide insight as to why some patients undergoing the heart procedure have better outcomes than others.
FDA Approves Abiomed’s First-in-Human Trial of Impella ECP, World’s Smallest Heart Pump
June 5, 2020
…
Medtronic Resolute Onyx DES Receives First and Only One-Month DAPT Indication for High Bleeding Risk Patients in Europe
June 5, 2020
DUBLIN, June 05, 2020 — Medtronic plc has received CE (Conformité Européenne) Mark for a one-month dual antiplatelet therapy (DAPT) indication for high bleeding risk (HBR) patients implanted with the Resolute Onyx™ Drug-Eluting Stent (DES). For HBR patients, whose bleeding risk may be increased by taking longer DAPT regimens (a combination of aspirin and an
BD Announces Launch of Halo One Thin-Walled Guiding Sheath
June 5, 2020
FRANKLIN LAKES, N.J.
HinaLea Imaging to Investigate Prognostic Value of “COVID-19 Rash” Using Advanced Hyperspectral Imaging
June 4, 2020
Whether these rashes are in fact ischemic remains to be determined, due to the paucity of data from biopsy and other invasive assessments.
FDA Clears Innovative Angioplasty Scoring and Cutting Platform
June 4, 2020
PARK CITY, Utah, June 4, 2020 — Transit Scientific announced the FDA cleared the XO Score Percutaneous Transluminal Angioplasty (PTA) Scoring Sheath platform for use in iliac, ilio-femoral, popliteal, infra-popliteal, and renal arterial plus synthetic and/or native arteriovenous
Fear of COVID-19 Keeping More Than Half of Heart Attack Patients Away From Hospitals
June 4, 2020
Heart attack patients worldwide avoid hospitals or present too late to benefit from life-saving treatment  
BD Completes Acquisition of Straub Medical
June 3, 2020
FRANKLIN LAKES, N.J. (June 1, 2020) – BD (Becton, Dickinson and Company) announced that it has completed the acquisition of Straub Medical AG, a privately-held company that develops and sells medical atherectomy and thrombectomy devices that treat peripheral arterial disease (PAD) and venous disease.
CeloNova Announces Enrollment Completion of World's First Randomized Control, 14-Day DAPT Trial
June 2, 2020
First-of-its-kind study evaluates ultra-short DAPT in PCI patients at high bleeding risk compared to drug-eluting stents
Minneapolis Heart Institute Foundation® and UC-San Diego Received FDA Approval of Investigational New Drug Application to Continue Research of Novel Hydrogel for Cardiac Tissue Repair
June 2, 2020
…